Study of effectiveness, tolerability and safety of intravenous iron sucrose in moderate anaemia in pregnancy
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20253902Keywords:
Iron deficiency anaemia, Injection iron sucrose, Moderate anaemia in pregnancyAbstract
Background: Iron deficiency is the most common cause of anaemia in pregnancy. The first choice in the treatment of iron deficiency anaemia for almost all patients is oral iron replacement because of its effectiveness, safety and low cost. Intravenous iron therapy is recommended during the second and third trimesters for women with moderate anaemia and those with noncompliance or intolerance to oral iron. This study aimed to assess the effectiveness, tolerability and safety of intravenous iron sucrose in moderate anaemia in pregnancy.
Methods: A longitudinal prospective study was conducted at a tertiary care center. The pregnant women with moderate anaemia with gestational age between 28 weeks and 34 weeks were administered intravenous iron sucrose in precalculated doses and rise in haemoglobin and other indices were measured after 3 weeks.
Results: Among 163 cases, baseline mean Hb level of 8.09±1.1 g/dl and serum ferritin level of 7.74±6.1 µg/l showed a statistically significant change to 12.07±1.4 g/dl and 89.12±62.43 µg/l respectively three weeks after treatment with intravenous iron sucrose. In addition, mean PCV, MCH and MCHC also improved significantly.
Conclusions: Parental iron therapy is safe and effective in increasing haemoglobin, serum ferritin and other hematological parameters in pregnant women with moderate anaemia. It can be used as a treatment of choice in patients with intolerance or non- compliance to oral iron therapy. Intravenous iron sucrose injection is found to be safe and tolerable with good efficacy in the treatment of moderate anaemia.
Metrics
References
Stevens GA, Finucane MM, De-Regil LM, Paciorek CJ, Flaxman SR, Branca F, et al. Global, regional, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non-pregnant women for 1995–2011: a systematic analysis of population-representative data. Lancet Global Health. 2013;1(1):e16-25. DOI: https://doi.org/10.1016/S2214-109X(13)70001-9
World Health Organization. Anaemia in women and children, 2025. Available at: https://www.who.int/data/gho/data/themes/topics/anaemia_in_women_and_children. Accessed 01 June 2025.
Dutta RR, Chhabra P, Kumar T, Joshi A. Tackling Anemia in Pregnant Women in India: Reviewing the Obstacles and Charting a Path Forward. Cureus. 2023;15(8): e43123. DOI: https://doi.org/10.7759/cureus.43123
Obeagu EI, Adepoju OJ, Okafor CJ, Obeagu GU, Ibekwe AM, Okpala PU, et al. Assessment of Haematological Changes in Pregnant Women of Ido, Ondo State, Nigeria. J Res Med Dent Sci. 2021;9(4):145-8.
Obeagu GU, Obeagu EI. Complications of anemia in pregnancy: An updated overview for healthcare professionals. Medicine (Baltimore). 2025;104(35):e44246. DOI: https://doi.org/10.1097/MD.0000000000044246
Sharma JB, Soni D. Oxidative stress in pregnancy - role of iron therapy: oral iron therapy and risk of free radicals. Obstet and gynecol. 2001;6(12):705-6.
Bashiri A, Burstein E, Sheiner E, Mazor M. Anemia during pregnancy and treatment with intravenous iron: review of the literature. Eur J Obstet Gynecol Reprod Biol. 2003;110(1):2-7. DOI: https://doi.org/10.1016/S0301-2115(03)00113-1
Kaur R, Kant S, Subramanian M, Kamble BD, Malhotra S, Haldar P, et al. Effectiveness of intravenous iron sucrose therapy in routine antenatal care for the treatment of moderate to severe anemia among pregnant women attending a secondary care hospital in north India: a retrospective analysis. Cureus. 2022;14(3). DOI: https://doi.org/10.7759/cureus.23603
Koch TA, Myers J, Goodnough LT. Intravenous iron therapy in patients with iron deficiency anemia: dosing considerations. Anemia. 2015;2015(1):763576. DOI: https://doi.org/10.1155/2015/763576
Giannoulis C, Daniilidis A, Tantanasis T, Dinas K, Tzafettas J. Intravenous administration of iron sucrose for treating anemia in postpartum women. Hippokratia. 2009;13(1):38.
Rudra S, Chandna A, Nath J. Comparison of intravenous iron sucrose with oral iron in pregnant women with iron deficiency anaemia. Int J Reprod Contracept Obstet Gynecol. 2017;5(3):747-51. DOI: https://doi.org/10.18203/2320-1770.ijrcog20160577
Marpaung J, Dewi MS, Effendi IH, Dina S, Asroel EM, Situmorang MF, et al. The study of efficacy of injection iron sucrose in treatment of iron deficiency anemia in pregnancy. Int J Reprod Contracept Obstet Gynecol. 2019; 8(6):2444-8. DOI: https://doi.org/10.18203/2320-1770.ijrcog20192447
Niranjana R, Rajeswari KR. Study of effectiveness, tolerability and safety of intravenous iron sucrose in iron deficiency anaemia in postnatal women. Int J Reprod Contracept Obstet Gynecol. 2018;7(11):4366-9. DOI: https://doi.org/10.18203/2320-1770.ijrcog20184245
Cançado RD, Figueiredo PO, Olivato MC, Chiattone CS. Efficacy and safety of intravenous iron sucrose in treating adults with iron deficiency anaemia. Rev Bras Hematol Hemoter. 2011;33(6):439-43. DOI: https://doi.org/10.5581/1516-8484.20110119
Nanthini R, Mamatha K, Shivamurthy G, Kavitha R. A prospective study to assess the efficacy and safety of iron sucrose in pregnant women with iron deficiency anemia in a tertiary care hospital. Int J Basic Clin Pharmacol. 2015;4(6):1271-5. DOI: https://doi.org/10.18203/2319-2003.ijbcp20151371
Downloads
Published
How to Cite
Issue
Section
